Alto Neuroscience
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $394 | $0 |
Gross Profit | -100 | -171 | 197 | -200 |
EBITDA | -18,682 | -14,400 | -14,698 | -16,312 |
EBIT | -18,782 | -14,571 | -14,868 | -16,434 |
Net Income | -17,706 | -15,169 | -15,201 | -16,783 |
Net Change In Cash | 0 | 0 | 394 | 0 |
Free Cash Flow | -13,779 | -16,580 | -13,527 | -12,731 |
Cash | 147,585 | 160,754 | 168,229 | 181,701 |
Basic Shares | 27,072 | 27,049 | 26,986 | 26,959 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $210 |
Gross Profit | -502 | -373 | -342 | 65 |
EBITDA | -68,610 | -34,562 | -27,368 | -9,042 |
EBIT | -62,806 | -34,935 | -27,710 | -9,187 |
Net Income | -61,431 | -36,305 | -27,710 | -9,187 |
Net Change In Cash | 0 | 0 | 0 | 210 |
Free Cash Flow | -49,499 | -33,918 | -21,126 | -9,942 |
Cash | 168,229 | 82,548 | 48,344 | 25,705 |
Basic Shares | 24,602 | 26,883 | 25,574 | 25,574 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.65 |
2025-03-31 | -$0.56 |
2024-12-31 | -$0.52 |
